Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)

NCT06099184 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: EYP-1901
DRUG: Aflibercept 2Mg/0.05Ml Inj,Oph

Sponsor

EyePoint Pharmaceuticals, Inc.